CEO & Co-Founder Idevax, Co-Founder Novosanis, passionate entrepreneur, driven by microbiology, vaccinology and medical devices, but also caring mother of two
Representing @Idevax1 at #leuvenslushd today. Looking forward to an exciting afternoon with pitches, panel talks, keynotes and for sure a lot of networking!
Day 2 at #microneedlesconference in Seattle. Pass by our @Idevax1 booth to learn more about VAX-ID for intradermal #vaccination and get a little box of Belgian chocolates! See you soon 😊
Day 1 at #microneedlesconference in the beautiful city of Seattle, US. Looking forward to presenting our poster nr 49 today and meeting you at our @Idevax1 booth
📢IDEVAX is ISO 13485:2016 certified📢
We are very proud to announce that IDEVAX is ISO 13485:2016 certified. The certificate has been issued by notified body ECM. IDEVAX is now certified for its quality management system.
Link to the news 👉 https://t.co/sTP8M77JkT
Thank you! #IPVC2023 Loved the networking and being able to share our work on #VAXID by @Idevax1
See you in Edinburgh in 2024 for more on #hpv and elimination of hpv-related cancers 😊😎
I was honoured to attend #ipvc2023 and discuss intradermal delivery possibilities for HPV vaccines with VAX-ID. See you next time at #ipvc2024! #ipvc2023reunion
To eliminate cervical cancer we need to work together! Indigenous people should not be left out. Love this quote: “through the eye of the needle pass the white thread, the black thread and the red thread” thanks Bev Lawton for sharing! #ipvc2023#IPVC2023Reunion
Attending #ipvc2023
Looking forward to fruitful days representing @Idevax1 and learning more about #hpv#vaccines in the battle against hpv-related cancers
Great energy during our Scientific Advisory Board with amazing experts! Loved the learning experience on human and veterinary vaccination #Vaccines#vaccination#science
IDEVAX Scientific Advisory Board 🧬 🔬 🧫
Throwback to last Monday! Our Scientific Advisory Board convened at Vaccinopolis, an impressive clinical trial facility with a clear focus on vaccination trials, in Antwerp, Belgium.
Link to the news 👉 https://t.co/nVi5kxLPM5
📢 WHO is recommending the use of mpox over Monkeypox 📰 Idevax supports WHO’s recommendation to change Monkeypox to mpox. Accordingly, we revised our white paper on mpox outbreak using WHO’s recommended synonym.
News is👉 https://t.co/fAquViUuxq